Tags

Type your tag names separated by a space and hit enter

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach.
PLoS Negl Trop Dis. 2023 07; 17(7):e0011514.PN

Abstract

BACKGROUND

Human African trypanosomiasis is a parasitic disease caused by trypanosomes among which Trypanosoma brucei gambiense is responsible for a chronic form (gHAT) in West and Central Africa. Its elimination as a public health problem (EPHP) was targeted for 2020. Côte d'Ivoire was one of the first countries to be validated by WHO in 2020 and this was particularly challenging as the country still reported around a hundred cases a year in the early 2000s. This article describes the strategies implemented including a mathematical model to evaluate the reporting results and infer progress towards sustainable elimination.

METHODS

The control methods used combined both exhaustive and targeted medical screening strategies including the follow-up of seropositive subjects- considered as potential asymptomatic carriers to diagnose and treat cases- as well as vector control to reduce the risk of transmission in the most at-risk areas. A mechanistic model was used to estimate the number of underlying infections and the probability of elimination of transmission (EoT) was met between 2000-2021 in two endemic and two hypo-endemic health districts.

RESULTS

Between 2015 and 2019, nine gHAT cases were detected in the two endemic health districts of Bouaflé and Sinfra in which the number of cases/10,000 inhabitants was far below 1, a necessary condition for validating EPHP. Modelling estimated a slow but steady decline in transmission across the health districts, bolstered in the two endemic health districts by the introduction of vector control. The decrease in underlying transmission in all health districts corresponds to a high probability that EoT has already occurred in Côte d'Ivoire.

CONCLUSION

This success was achieved through a multi-stakeholder and multidisciplinary one health approach where research has played a major role in adapting tools and strategies to this large epidemiological transition to a very low prevalence. This integrated approach will need to continue to reach the verification of EoT in Côte d'Ivoire targeted by 2025.

Authors+Show Affiliations

Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Laboratoire de Biodiversité et Gestion des Ecosystèmes Tropicaux, Unité de Recherche en Génétique et Epidémiologie Moléculaire, UFR Environnement, Université Jean Lorougnon Guédé, Daloa, Côte d'Ivoire.Programme National d'Élimination de la Trypanosomiase Humaine Africaine, Abidjan, Côte d'Ivoire.Projet de Recherches Cliniques sur la Trypanosomiase, Daloa, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Unité Mixte de Recherche IRD-CIRAD 177, INTERTRYP, Institut de Recherche pour le Développement, Université de Montpellier, Montpellier, France.Laboratoire de Biodiversité et Gestion des Ecosystèmes Tropicaux, Unité de Recherche en Génétique et Epidémiologie Moléculaire, UFR Environnement, Université Jean Lorougnon Guédé, Daloa, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire. Laboratoire de Biodiversité et Gestion des Ecosystèmes Tropicaux, Unité de Recherche en Génétique et Epidémiologie Moléculaire, UFR Environnement, Université Jean Lorougnon Guédé, Daloa, Côte d'Ivoire.Laboratoire de Biodiversité et Gestion des Ecosystèmes Tropicaux, Unité de Recherche en Génétique et Epidémiologie Moléculaire, UFR Environnement, Université Jean Lorougnon Guédé, Daloa, Côte d'Ivoire.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Warwick Medical School, University of Warwick, Coventry, United Kingdom.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Mathematics Institute, Zeeman Building, The University of Warwick, Coventry, United Kingdom.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Mathematics Institute, Zeeman Building, The University of Warwick, Coventry, United Kingdom.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Warwick Medical School, University of Warwick, Coventry, United Kingdom.Independent Consultant, Edinburgh, United Kingdom.Unité Mixte de Recherche IRD-CIRAD 177, INTERTRYP, Institut de Recherche pour le Développement, Université de Montpellier, Montpellier, France.Unité Mixte de Recherche IRD-CIRAD 177, INTERTRYP, Institut de Recherche pour le Développement, Université de Montpellier, Montpellier, France.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Mathematics Institute, Zeeman Building, The University of Warwick, Coventry, United Kingdom.Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematical Sciences Building, The University of Warwick, Coventry, United Kingdom. Mathematics Institute, Zeeman Building, The University of Warwick, Coventry, United Kingdom.Unité de Recherche « Trypanosomoses », Institut Pierre Richet, Bouaké, Côte d'Ivoire. Unité Mixte de Recherche IRD-CIRAD 177, INTERTRYP, Institut de Recherche pour le Développement, Université de Montpellier, Montpellier, France.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

37523361

Citation

Kaba, Dramane, et al. "Towards the Sustainable Elimination of Gambiense Human African Trypanosomiasis in Côte d'Ivoire Using an Integrated Approach." PLoS Neglected Tropical Diseases, vol. 17, no. 7, 2023, pp. e0011514.
Kaba D, Koffi M, Kouakou L, et al. Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach. PLoS Negl Trop Dis. 2023;17(7):e0011514.
Kaba, D., Koffi, M., Kouakou, L., N'Gouan, E. K., Djohan, V., Courtin, F., N'Djetchi, M. K., Coulibaly, B., Adingra, G. P., Berté, D., Ta, B. T. D., Koné, M., Traoré, B. M., Sutherland, S. A., Crump, R. E., Huang, C. I., Madan, J., Bessell, P. R., Barreaux, A., ... Jamonneau, V. (2023). Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach. PLoS Neglected Tropical Diseases, 17(7), e0011514. https://doi.org/10.1371/journal.pntd.0011514
Kaba D, et al. Towards the Sustainable Elimination of Gambiense Human African Trypanosomiasis in Côte d'Ivoire Using an Integrated Approach. PLoS Negl Trop Dis. 2023;17(7):e0011514. PubMed PMID: 37523361.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach. AU - Kaba,Dramane, AU - Koffi,Mathurin, AU - Kouakou,Lingué, AU - N'Gouan,Emmanuel Kouassi, AU - Djohan,Vincent, AU - Courtin,Fabrice, AU - N'Djetchi,Martial Kassi, AU - Coulibaly,Bamoro, AU - Adingra,Guy Pacôme, AU - Berté,Djakaridja, AU - Ta,Bi Tra Dieudonné, AU - Koné,Minayégninrin, AU - Traoré,Barkissa Mélika, AU - Sutherland,Samuel A, AU - Crump,Ronald E, AU - Huang,Ching-I, AU - Madan,Jason, AU - Bessell,Paul R, AU - Barreaux,Antoine, AU - Solano,Philippe, AU - Crowley,Emily H, AU - Rock,Kat S, AU - Jamonneau,Vincent, Y1 - 2023/07/31/ PY - 2023/01/24/received PY - 2023/07/07/accepted PY - 2023/08/22/revised PY - 2023/8/24/medline PY - 2023/7/31/pubmed PY - 2023/7/31/entrez SP - e0011514 EP - e0011514 JF - PLoS neglected tropical diseases JO - PLoS Negl Trop Dis VL - 17 IS - 7 N2 - BACKGROUND: Human African trypanosomiasis is a parasitic disease caused by trypanosomes among which Trypanosoma brucei gambiense is responsible for a chronic form (gHAT) in West and Central Africa. Its elimination as a public health problem (EPHP) was targeted for 2020. Côte d'Ivoire was one of the first countries to be validated by WHO in 2020 and this was particularly challenging as the country still reported around a hundred cases a year in the early 2000s. This article describes the strategies implemented including a mathematical model to evaluate the reporting results and infer progress towards sustainable elimination. METHODS: The control methods used combined both exhaustive and targeted medical screening strategies including the follow-up of seropositive subjects- considered as potential asymptomatic carriers to diagnose and treat cases- as well as vector control to reduce the risk of transmission in the most at-risk areas. A mechanistic model was used to estimate the number of underlying infections and the probability of elimination of transmission (EoT) was met between 2000-2021 in two endemic and two hypo-endemic health districts. RESULTS: Between 2015 and 2019, nine gHAT cases were detected in the two endemic health districts of Bouaflé and Sinfra in which the number of cases/10,000 inhabitants was far below 1, a necessary condition for validating EPHP. Modelling estimated a slow but steady decline in transmission across the health districts, bolstered in the two endemic health districts by the introduction of vector control. The decrease in underlying transmission in all health districts corresponds to a high probability that EoT has already occurred in Côte d'Ivoire. CONCLUSION: This success was achieved through a multi-stakeholder and multidisciplinary one health approach where research has played a major role in adapting tools and strategies to this large epidemiological transition to a very low prevalence. This integrated approach will need to continue to reach the verification of EoT in Côte d'Ivoire targeted by 2025. SN - 1935-2735 UR - https://www.unboundmedicine.com/medline/citation/37523361/Towards_the_sustainable_elimination_of_gambiense_human_African_trypanosomiasis_in_Côte_d'Ivoire_using_an_integrated_approach_ DB - PRIME DP - Unbound Medicine ER -